MAP2K2

GENERAL INFORMATION

? »

Gene name

MAP2K2

Gene description

Mitogen-activated protein kinase kinase 2

Protein class

Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins

Predicted localization

Intracellular

Number of transcripts

3
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

? »

RNA tissue category

HPA:Expressed in all
GTEx:Expressed in all

Protein evidence

Evidence at protein level

Protein localization

General cytoplasmic expression, most abundant in the intestine.

ANTIBODY RELIABILITY

? »

Data reliability
description

Pending RNA-based expert annotation.

Data reliability

Supportive based on 2 antibodies.
HPA051993 , CAB003835
SHOW MORE

RNA AND PROTEIN EXPRESSION SUMMARY

? »
RNA expression (FPKM) Protein expression (score)
Brain
Endocrine tissues
Bone marrow & immune system
Muscle tissues
Lung
Liver & gallbladder
Pancreas
Gastrointestinal tract
Kidney & urinary bladder
Male tissues
Female tissues
Adipose & soft tissue
Skin
Cerebral cortex

Lymph node

Liver

Colon

Kidney

Testis

Skin



PROTEIN EXPRESSION OVERVIEW

? »

Organ

Expression



RNA EXPRESSION OVERVIEW

? »
HPA dataset
RNA tissue category:  Expressed in all

Organ

Expression

GTEx dataset
RNA tissue category:  Expressed in all

Organ

Expression



GENE INFORMATION

? »

Gene name

MAP2K2 (HGNC Symbol)

Synonyms

MEK2, PRKMK2

Description

Mitogen-activated protein kinase kinase 2 (HGNC Symbol)

Entrez gene summary

The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, mental retardation, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. [provided by RefSeq, Jul 2008]

Chromosome

19

Cytoband

p13.3

Chromosome location (bp)

4090321 - 4124129

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000126934 (version 78.38)

Entrez gene

5605

UniProt

P36507 (UniProt - Evidence at protein level)

neXtProt

NX_P36507

Antibodypedia

MAP2K2 antibodies


PROTEIN BROWSER

? »
 
 
 
ENST00000262948
 
ENST00000394867
 
ENST00000599021
 
 
 
 


PROTEIN INFORMATION

? »

Splice variant

Ensembl

UniProt

Protein class

Gene ontology

Length
(aa)

Molecular mass
(kDa)

Signal peptide
(predicted)

Transmembrane regions
(predicted)

MAP2K2-001 ENSP00000262948
ENST00000262948
P36507
Show all »
Show » Show » 400 44.4 No 0
MAP2K2-010 ENSP00000471763
ENST00000599021
Show » Show » 104 11.6 No 0
MAP2K2-201 ENSP00000378336
ENST00000394867
G5E9C7
Show all »
Show » Show » 303 33.9 No 0